Legal Insights

< back to search results

FDA unveils ramped-up regulatory initiatives for drug compounders

Overview

On September 26, 2017, US Food and Drug Administration Commissioner Scott Gottlieb, M.D. released a statement about the FDA's ramped up regulatory initiatives for drug compounders.


Drug compounders should continue to closely monitor their compliance with all applicable state and federal regulation and guidance.


This briefing looks at the proposals.